Rubric Capital Management
Latest statistics and disclosures from Rubric Capital Management's latest quarterly 13F-HR filing:
- Top 5 stock holdings are IWM, TEVA, GLNG, VTRS, ROIV, and represent 32.64% of Rubric Capital Management's stock portfolio.
- Added to shares of these 10 stocks: IWM (+$265M), BGC (+$106M), ROIV (+$81M), NRG (+$24M), IMVT (+$22M), QDEL (+$22M), RVNC (+$18M), HRTX (+$15M), MSGS (+$15M), PCRX (+$14M).
- Started 11 new stock positions in BGC, IMVT, RSKD, RVNC, ARDX, SSYS, IWM, PCRX, QDEL, MSGS. CNDT.
- Reduced shares in these 10 stocks: , VST (-$73M), LC (-$52M), STNG (-$49M), FLR (-$38M), PARR (-$26M), CCO (-$17M), RDNT (-$17M), PLYA (-$15M), DBRG (-$12M).
- Sold out of its positions in ABUS, BGC Partners, DMRC, DBRG, KPTI, LC, PENN, Point Biopharma Global, RDNT, SPCE. FREE, STNG.
- Rubric Capital Management was a net buyer of stock by $259M.
- Rubric Capital Management has $2.7B in assets under management (AUM), dropping by 14.00%.
- Central Index Key (CIK): 0001687509
Tip: Access up to 7 years of quarterly data
Positions held by Rubric Capital Management consolidated in one spreadsheet with up to 7 years of data
Download as csv
Download as Excel
Portfolio Holdings for Rubric Capital Management
Rubric Capital Management holds 61 positions in its portfolio as reported in the September 2023 quarterly 13F filing
| Company (Ticker) | Portfolio Weight | Valued At | Change in Shares | Share Count | Share Price | |
|---|---|---|---|---|---|---|
| Ishares Tr Russell 2000 Etf Put Option (IWM) | 9.9 | $265M | NEW | 1.5M | 176.74 |
|
| Teva Pharmaceutical Inds Sponsored Ads (TEVA) | 7.3 | $194M | 19M | 10.20 |
|
|
| Golar Lng SHS (GLNG) | 5.9 | $158M | 6.5M | 24.26 |
|
|
| Viatris (VTRS) | 4.9 | $131M | +10% | 13M | 9.86 |
|
| Roivant Sciences SHS (ROIV) | 4.6 | $123M | +196% | 11M | 11.68 |
|
| Bgc Group Cl A (BGC) | 4.0 | $106M | NEW | 20M | 5.28 |
|
| Mr Cooper Group (COOP) | 3.9 | $105M | 2.0M | 53.56 |
|
|
| Cameco Corporation (CCJ) | 3.8 | $100M | -6% | 2.5M | 39.64 |
|
| Fluor Corporation (FLR) | 3.3 | $87M | -30% | 2.4M | 36.70 |
|
| Aar (AIR) | 2.7 | $73M | 1.2M | 59.53 |
|
|
| Collegium Pharmaceutical Inc Common Stock Usd (COLL) | 2.7 | $71M | -7% | 3.2M | 22.35 |
|
| Par Pac Holdings Com New (PARR) | 2.7 | $71M | -26% | 2.0M | 35.94 |
|
| Hertz Global Hldgs Com New (HTZ) | 2.4 | $63M | -9% | 5.2M | 12.25 |
|
| Schweitzer-Mauduit International (MATV) | 2.1 | $57M | +16% | 4.0M | 14.26 |
|
| Renew Energy Global Cl A Shs (RNW) | 2.0 | $54M | +21% | 9.9M | 5.43 |
|
| Kiniksa Pharmaceuticals Com Cl A (KNSA) | 2.0 | $54M | -8% | 3.1M | 17.37 |
|
| Nrg Energy Com New (NRG) | 1.9 | $51M | +91% | 1.3M | 38.52 |
|
| Adeia (ADEA) | 1.9 | $50M | 4.6M | 10.68 |
|
|
| Biosante Pharmaceuticals (ANIP) | 1.8 | $49M | 847k | 58.06 |
|
|
| Koppers Holdings (KOP) | 1.7 | $45M | +6% | 1.1M | 39.55 |
|
| Orthofix Medical (OFIX) | 1.7 | $44M | +43% | 3.4M | 12.86 |
|
| Dole Ord Shs (DOLE) | 1.6 | $43M | +2% | 3.7M | 11.58 |
|
| Pactiv Evergreen (PTVE) | 1.5 | $41M | +3% | 5.0M | 8.13 |
|
| Xperi Common Stock (XPER) | 1.5 | $40M | +5% | 4.0M | 9.86 |
|
| Hollysys Automation Tchngy L SHS (HOLI) | 1.4 | $39M | 1.9M | 19.84 |
|
|
| Transalta Corp (TAC) | 1.4 | $38M | +28% | 4.4M | 8.70 |
|
| Playa Hotels & Resorts Nv SHS (PLYA) | 1.4 | $38M | -27% | 5.2M | 7.24 |
|
| Constellium Se Cl A Shs (CSTM) | 1.3 | $36M | -12% | 2.0M | 18.20 |
|
| Magnite Ord (MGNI) | 1.1 | $30M | +80% | 4.0M | 7.54 |
|
| Heron Therapeutics (HRTX) | 1.0 | $28M | +127% | 27M | 1.03 |
|
| Arcutis Biotherapeutics (ARQT) | 1.0 | $27M | +3% | 5.0M | 5.31 |
|
| Immunovant Put Option (IMVT) | 0.8 | $22M | NEW | 570k | 38.39 |
|
| Quidel Corp (QDEL) | 0.8 | $22M | NEW | 296k | 73.04 |
|
| Ovid Therapeutics (OVID) | 0.8 | $21M | 5.4M | 3.84 |
|
|
| Vistra Energy (VST) | 0.7 | $20M | -78% | 602k | 33.18 |
|
| Scpharmaceuticals (SCPH) | 0.7 | $19M | +234% | 2.7M | 7.12 |
|
| Revance Therapeutics (RVNC) | 0.7 | $18M | NEW | 1.6M | 11.47 |
|
| Adapthealth Corp Common Stock (AHCO) | 0.7 | $18M | -31% | 2.0M | 9.10 |
|
| Amneal Pharmaceuticals Com Stk Cl A (AMRX) | 0.6 | $17M | +54% | 4.0M | 4.22 |
|
| Zymeworks Del (ZYME) | 0.6 | $17M | +12% | 2.7M | 6.34 |
|
| Mereo Biopharma Group Spon Ads (MREO) | 0.6 | $15M | 12M | 1.29 |
|
|
| Omniab (OABI) | 0.6 | $15M | +306% | 2.9M | 5.19 |
|
| Madison Square Grdn Sprt Cor Cl A (MSGS) | 0.6 | $15M | NEW | 84k | 176.30 |
|
| Pacira Pharmaceuticals (PCRX) | 0.5 | $14M | NEW | 460k | 30.68 |
|
| Telesat Corp Cl A & Cl B Shs (TSAT) | 0.5 | $14M | -24% | 960k | 14.30 |
|
| Stratasys SHS (SSYS) | 0.5 | $12M | NEW | 911k | 13.61 |
|
| Trevi Therapeutics (TRVI) | 0.5 | $12M | 5.7M | 2.18 |
|
|
| Sutro Biopharma (STRO) | 0.4 | $12M | -17% | 3.3M | 3.47 |
|
| Clear Channel Outdoor Holdings (CCO) | 0.4 | $11M | -61% | 6.7M | 1.58 |
|
| Ftai Infrastructure Common Stock (FIP) | 0.4 | $10M | 3.2M | 3.22 |
|
|
| Ardelyx (ARDX) | 0.4 | $10M | NEW | 2.5M | 4.08 |
|
| Magnachip Semiconductor Corp (MX) | 0.3 | $8.0M | 968k | 8.31 |
|
|
| Riskified Shs Cl A (RSKD) | 0.3 | $7.2M | NEW | 1.6M | 4.48 |
|
| Playstudios Class A Com (MYPS) | 0.2 | $6.2M | 2.0M | 3.18 |
|
|
| Cullinan Oncology (CGEM) | 0.2 | $5.7M | 627k | 9.05 |
|
|
| Werewolf Therapeutics (HOWL) | 0.2 | $4.1M | 1.9M | 2.14 |
|
|
| Bicycle Therapeutics Sponsored Ads (BCYC) | 0.2 | $4.1M | 205k | 20.09 |
|
|
| Therapeuticsmd Com New (TXMD) | 0.1 | $3.6M | 1.2M | 3.02 |
|
|
| Conduent Incorporate (CNDT) | 0.1 | $2.9M | NEW | 835k | 3.48 |
|
| Silverback Therapeutics (SPRY) | 0.1 | $2.4M | -77% | 639k | 3.78 |
|
| Vincerx Pharma Com New (VINC) | 0.0 | $358k | 354k | 1.01 |
|
Past Filings by Rubric Capital Management
SEC 13F filings are viewable for Rubric Capital Management going back to 2016
- Rubric Capital Management 2023 Q3 restated filed Nov. 15, 2023
- Rubric Capital Management 2023 Q3 filed Nov. 14, 2023
- Rubric Capital Management 2023 Q2 filed Aug. 11, 2023
- Rubric Capital Management 2023 Q1 filed May 12, 2023
- Rubric Capital Management 2022 Q4 filed Feb. 10, 2023
- Rubric Capital Management 2022 Q3 filed Nov. 14, 2022
- Rubric Capital Management 2022 Q2 restated filed Aug. 15, 2022
- Rubric Capital Management 2022 Q2 filed Aug. 12, 2022
- Rubric Capital Management 2022 Q1 filed May 13, 2022
- Rubric Capital Management 2021 Q4 filed Feb. 14, 2022
- Rubric Capital Management 2021 Q3 filed Nov. 12, 2021
- Rubric Capital Management 2021 Q2 filed Aug. 13, 2021
- Rubric Capital Management 2021 Q1 filed May 14, 2021
- Rubric Capital Management 2020 Q4 filed Feb. 16, 2021
- Rubric Capital Management 2020 Q3 filed Nov. 13, 2020
- Rubric Capital Management 2020 Q2 filed Aug. 10, 2020